J&J | الأصول



Assets تغيير تاريخ
AbbVie USD 135.16B 8.26B 2024-12
Abbott USD 81.45B 34M 2025-03
Amgen USD 89.37B 2.47B 2025-03
AstraZeneca USD 106.25B 2.22B 2025-03
Baxter International USD 25.78B 894M 2024-12
Bayer EUR 109.18B 1.67B 2025-03
Becton, Dickinson and Co. USD 54.47B 198M 2025-03
Biogen USD 28.03B 16.2M 2025-03
Boston Scientific USD 40.14B 745M 2025-03
Bristol-Myers Squibb USD 92.43B 176M 2025-03
CONMED USD 2.3B 8.56M 2025-03
Cooper Companies USD 12.22B 93M 2025-01
Dexcom USD 6.75B 267.2M 2025-03
Edwards Lifesciences USD 13.06B 84.1M 2024-12
Eli Lilly USD 89.39B 10.67B 2025-03
Gilead Sciences USD 56.43B 2.56B 2025-03
GlaxoSmithKline GBP 60.71B 1.24B 2025-03
Globus Medical USD 4.71B 540.6M 2025-03
Hologic USD 8.55B 183.6M 2025-03
Indivior 1.38B 56M 2025-03
Insulet USD 3.52B 429.6M 2025-03
Integra LifeSciences USD 4.05B 15.33M 2025-03
Intuitive Surgical USD 19.22B 477.2M 2025-03
J&J USD 193.67B 13.57B 2025-03
Medtronic USD 91.68B 1.71B 2025-04
Merck USD 115.12B 1.98B 2025-03
Merit Medical Systems USD 2.47B 49.37M 2025-03
Novartis USD 102.25B 1.28B 2024-12
Pfizer USD 208.03B 5.37B 2025-03
Regeneron Pharmaceuticals USD 37.55B 214.2M 2025-03
Roche Holding CHF 101.8B 6.02B 2024-12
Sanofi 131.89B 906M 2025-03
Stryker USD 46.01B 3.04B 2025-03
Tandem Diabetes Care USD 922.14M 45.52M 2025-03
Teva Pharmaceutical Industries USD 38.42B 911M 2025-03
Vertex Pharmaceuticals USD 22.53B 293M 2024-12
Zimmer Biomet Holdings USD 21.37B 355M 2024-12
Zoetis USD 14.1B 139M 2025-03



J&J الأصول - القيم الحالية، والبيانات التاريخية، والتنبؤات والإحصاءات والرسوم البيانية والتقويم الاقتصادي - May 2025.